Optimus Pharma Profile
Key Indicators
- Authorised Capital ₹ 44.00 Cr
- Paid Up Capital ₹ 37.68 Cr
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.80 Cr
- Satisfied Charges ₹ 44.97 Cr
- Revenue Growth -44.38%
- Profit Growth -116.67%
- Ebitda -107.10%
- Net Worth 31.48%
- Total Assets 1.71%
About Optimus Pharma
Optimus Pharma Private Limited (OPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 September 2004 and has a history of 20 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 44.00 Cr and a paid-up capital of Rs 37.68 Cr.
The company currently has active open charges totaling ₹21.80 Cr. The company has closed loans amounting to ₹44.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Optimus Pharma Private Limited India is Ritali Tangudu as COMPANY SECRETARY. Srinivasareddy Desireddy, Uma Rao, Anil Khubchandani, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG2004PTC044232
- Company No.
044232
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2004
- Date of AGM
21 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Optimus Pharma Private Limited offer?
Optimus Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Antiviral Drugs, Cardiovascular Drugs & Medication, Kidney Drugs, Antibacterial Drugs, Anticoagulant and Antiplatelet Drugs, Common Disease Medicines, Pharmaceutical Capsules.
Who are the key members and board of directors at Optimus Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ritali Tangudu | Company Secretary | 25-Feb-2023 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uma Rao  | Additional Director | 14-May-2024 | Current |
| Srinivasareddy Desireddy | Director | 21-Sep-2004 | Current |
| Anil Khubchandani | Director | 26-Jun-2023 | Current |
| Harsha Poluru | Director | 23-Sep-2022 | Current |
| Pagadala Baskarannarayanan | Director | 19-Oct-2022 | Current |
Financial Performance of Optimus Pharma.
Optimus Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.38% decrease. The company also saw a substantial fall in profitability, with a 116.67% decrease in profit. The company's net worth Soared by an impressive increase of 31.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Optimus Pharma?
In 2023, Optimus Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Optimus Drugs Private LimitedSrinivasareddy Desireddy, Uma Rao and 3 more are mutual person
- Optimus Life Science Private Limited
Uma Rao, Anil Khubchandani and 1 more are mutual person
Jubilant Ingrevia LimitedAnil Khubchandani is a mutual person
Anjan Drug Private LimitedAnil Khubchandani and Pagadala Baskarannarayanan are mutual person
Bay Sands Projects LlpSrinivasareddy Desireddy is a mutual person
- Orygamus Laboratories Private Limited
Srinivasareddy Desireddy is a mutual person
Charges (Loans)
₹21.80 Cr
₹44.97 Cr
Charges Breakdown by Lending Institutions
- Others : 21.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2016 | Others | ₹21.80 Cr | Open |
| 06 Nov 2020 | Others | ₹3.80 Cr | Satisfied |
| 13 Feb 2020 | Others | ₹20.00 Cr | Satisfied |
| 12 Oct 2011 | Standard Chartered Bank | ₹2.50 M | Satisfied |
| 12 Oct 2011 | Standard Chartered Bank | ₹11.50 Cr | Satisfied |
How Many Employees Work at Optimus Pharma?
Optimus Pharma has a workforce of 261 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Optimus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optimus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
